12.09.24 -- Companies To Watch: Terns Pharmaceuticals

Experience a new standard of collaboration with PROGRAMview™, KBI Biopharma's innovative client collaboration platform. Designed to bring clarity and efficiency to your drug development projects, PROGRAMview™ puts real-time process and analytical data at your fingertips. With tools for data visualization, team discussions, and quick decision-making, PROGRAMview™ is the central hub for all critical project data and teamwork. Empower your drug development journey with streamlined data sharing and collaboration across departments. More.

Disparate data systems present challenges, yet clinical trial platforms provide centralized integration, standardization, advanced analytics, and strong security for an efficient solution.

Delve into the crucial role of Scope 3 emissions in the biopharma industry's sustainability journey, and learn more about the challenges and opportunities of managing these types of emissions.

Whether you are just starting or in the final stages, explore key steps for preparing your medicinal product for the European market, including insights on challenges, timelines, and a success story.

3D printing in pharmaceutics is advancing to offer innovative drug delivery applications. Discover the possibilities of forming stable suspension in printing ink from nanoformed materials.

Srinivasan Shanmugam, Ph.D., Executive Director of Pharmaceutical Sciences, discusses pediatric patient compliance, regulations impacting trial access, excipients within formulations, and more.

Learn how comprehensive financial transformation solutions address budgeting and site payment challenges, drive value across the study lifecycle, and deliver operational and business benefits.

Finding partners with the necessary skills to optimize AAV processes is crucial for minimizing risk. Understand considerations for advancing your therapy from concept to commercialization.